P125 Neoadjuvant pembrolizumab + chemotherapy vs placebo + chemotherapy followed by adjuvant pembrolizumab vs placebo for early TNBC: surgical outcomes from the phase 3 KEYNOTE-522 study

Bibliographic Details
Main Authors:	S. Kümmel, P. Schmid, N. Harbeck, M. Takahashi, M. Untch, J.-F. Boileau, J. Cortes, H. McArthur, R. Dent, J. O’Shaughnessy, L. Pusztai, T. Foukakis, Y.H. Park, R. Hui, F. Cardoso, C. Denkert, Y. Zhu, W. Pan, V. Karantza, P. Fasching
Format:	Article
Language:	English
Published:	Elsevier 2023-03-01
Series:	Breast
Online Access:	http://www.sciencedirect.com/science/article/pii/S0960977623002424

Internet